Get 50% OFF This Monsoon!
Prevest Denpro
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Prevest Denpro Limited is one of the world's leading dental materials manufacturer. With the continued emphasis on research & development, the Company has been constantly expanding its product range to meet growing needs of dental professionals. The Company was incorporated as 'Prevest Denpro Limited' on May 05, 1999 under the provisions of Companies Act, 1956, with the Registrar of Companies, Jammu & Kashmir with Mr. Atul Modi and Mrs. Namrata Modi as Founders and Promoters of the Company. The Company is primarily involved in the manufacturing and sale of dental materials.
The Company develop, manufacture and market a comprehensive portfolio of dental materials for diagnosing, treating and preventing dental conditions as well as improving the aesthetics of the human smile. The product offerings addresses majority of dentists' clinical needs for consumable dental materials. The product portfolio covers a wide spectrum of materials for endodontics, prosthodontics, orthodontics, periodontics, restorative dentistry, aesthetic dentistry and laboratory consumables. The products are sold in over 75 countries in the regions of Europe, Asia, South America, Middle East and Africa.
The manufacturing facility is located at Kartholi, Samba (Jammu & Kashmir), comprising of over 27,000 sq. ft. area and has an installed capacity of 200 MT p.a. for manufacturing of dental materials. Further, as per diversification plans, the Company is currently expanding manufacturing unit by setting up another manufacturing facility in over 16,000 sq. ft. area adjacent to existing unit for manufacturing new line of products including, hygiene products (sanitizers and disinfectants), oral hygiene products (mouth washes and mouth rinses), oral care products (medicated ointments, gels and creams for dental treatment) and biomaterials (i.e. bone augmentation materials). The proposed facility will be well-equipped with latest machineries and will be commissioned in Fiscal 2022.
The Company sell products through a network of 53 dealers spread over 16 states and 2 Union Territories in India and through 91 overseas agents spread over 75 countries. The Company primarily follow a business-to-business model for all dental products. Further, Company have started selling certain products to direct consumers on digital market platforms such as Amazon and through its own web-platform i.e. prevestdirect.com. It recently purchased an office in Gurugram, Haryana, which will be used for marketing of products to customers in the North Indian region. The Company is diversifying into manufacturing of disinfectants, oral hygiene products, oral healthcare and bio-material products as well.
The Company work with different dealers and overseas agents depending on their geographical reach, market knowledge, product and customer awareness as well as understanding of dental industry. The distribution network is aided by capable in-house sales and marketing team which liaise with dealers and overseas agents on a regular basis for customer inputs, market demands as well as positioning of products vis-à-vis products of competitors. The Company also has a research & development department that is responsible for development of high-quality innovative dental materials.
In the year 2000, the Company's first manufacturing unit was established at Digiana, in Jammu & Kashmir. In 2011, the second manufacturing unit was established at Samba, in J&K. In 2016, the Company won Sushruta Award for Best Dental Manufacture by the Indian Dental Associations'. In 2016, the Company received Certificate for Best Enterprise' in the field of manufacture of dental materials, India by the Socrates Committee, Oxford, UK. In 2017, the Company shifted manufacturing operations from first manufacturing unit to second manufacturing unit. In 2017, the Company won 'Northern Region Export Excellence Award' - Gold Trophy for outstanding export performance in the category of top exporter J&K - SME by FIEO (2017).
Promoters of the Company have collaboration with 5 reputed dental universities & institutions like, Terna Dental College & Hospital, Mumbai; A.B. Shetty Memorial Institute of Dental Sciences, Mangalore, Karnataka ; Army College of Dental Sciences, Secunderabad, Telangana; R.S.M.N.N. Sattha College of Pharmacy, Ahmednagar, Maharashtra and J.M.F.'s A.C.P.M. Dental College, Dhule, Maharashtra for exchange of technical knowledge and conducting training & research on dental materials. The Company also entered into license agreement with Sree Chitra Tirunal Institute for Medical Sciences & Technology, Trivandrum for obtaining the know-how and rights to manufacture bioactive bone cement based on calcium sulfate and calcium phospho-silicate composite (HA-BG) Granules. The Company also have an advisory board of dental professionals which provides an overall industry and business guidance to Board of Directors.
The Company largely face competition from international companies which includes Danaher Corporation, Dentsply Sirona, Voco, Institute Straumann AG, Osstem Implant Co. Ltd., Zimmer Biomet, Medicept UK Ltd., Mani Inc. KAVO G C, Ivoclar-Vivadent, Nobel Biocare, 3M, G C Dental and Shofu Dental. Further, some of the Indian companies which are considered to be as a part of the competitors include 3M India Ltd., Prime Dental Products Private Limited, OriKam Healthcare India Private Limited, Dental Avenue (I) Private Limited, Vishal Dentocare Pvt. Limited and D Tech Orthodontics Pvt Ltd. Further, the main raw materials which are required to manufacture dental products includes zinc oxide, pumice powder, aluminium chloride, camphor, glycerine, paraffin, zirconium oxide, eugenol, diatomaceous earth, waxes etc. which are procured by the Company from domestic vendors. Further, certain raw materials such as Aerosil, Bisphenol A Bis Propyl Ether, Ethoxylated Bisphenol A Dimethacrylate, Triethylene Glycol Dimethacrylate, Urethane Dimethacrylate, Glass Powders, Sodium Alginate etc. are imported from international vendors located in Germany, USA, Korea and China by the Company.
The products are certified with ISO 13485:2016 and EU CE mark, which makes eligible to market products in European Union and many other countries which have adopted EU medical devices directives. The Company is also certified by Breakthrough Management Quality Registrar (BMQR) for Good Manufacturing Practices for manufacture and sale of dental materials.
Prevest Denpro share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Prevest Denpro indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Prevest Denpro is valued compared to its competitors.
Prevest Denpro PE ratio helps investors understand what is the market value of each stock compared to Prevest Denpro 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Prevest Denpro evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Prevest Denpro generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Prevest Denpro in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Prevest Denpro shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Prevest Denpro compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Prevest Denpro over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Prevest Denpro helps investors get an insight into when they can enter or exit the stock. Key components of Prevest Denpro Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Prevest Denpro shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Prevest Denpro ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Prevest Denpro provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Prevest Denpro highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Prevest Denpro .
The balance sheet presents a snapshot of Prevest Denpro ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App